Alkermes plc. Payments to Acquire Other Investments
Alkermes plc. (ALKS) reported Payments to Acquire Other Investments of $1.19 million for the 6-month period ending 2013-09-30, per its 10-Q filed 2013-10-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2014-02-27
- Alkermes plc. payments to acquire other investments for the quarter ending 2012-03-31 was $0.00.
- Alkermes plc. payments to acquire other investments for fiscal 2012 was $231.00K, a 53.89% decline from fiscal 2011.
- Alkermes plc. payments to acquire other investments for fiscal 2011 was $501.00K, a 93.74% decline from fiscal 2010.
- Alkermes plc. payments to acquire other investments for fiscal 2010 was $8.00M.
| Period end | Payments to Acquire Other Investments 3 month | Payments to Acquire Other Investments 6 month | Payments to Acquire Other Investments 9 month | Payments to Acquire Other Investments 12 month |
|---|---|---|---|---|
| 2013-09-30 | $1.19M 10-Q · filed 2013-10-31 | |||
| 2012-03-31 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | $231.00K 10-KT · filed 2014-02-27 | ||
| 2011-12-31 | $231.00K 10-Q · filed 2013-01-31 | |||
| 2011-03-31 | $501.00K 10-K · filed 2013-05-23 | |||
| 2010-03-31 | $8.00M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |